China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 128,793 | 105,613 | 70,225 | 32,733 | 114,106 |
| Depreciation Amortization | 12,738 | 7,625 | 5,029 | 2,485 | 9,034 |
| Income taxes - deferred | -3,007 | -1,711 | -1,585 | -887 | -170 |
| Accounts receivable | -10,972 | -16,105 | -13,856 | -5,267 | -7,146 |
| Accounts payable and accrued liabilities | 2,967 | -2,295 | -3,001 | -3,697 | 5,349 |
| Other Working Capital | -36,322 | -41,069 | -27,266 | -14,975 | -28,544 |
| Other Operating Activity | 29,060 | 35,258 | 27,468 | 13,840 | 16,765 |
| Operating Cash Flow | $123,259 | $87,317 | $57,013 | $24,232 | $109,392 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48,978 | -40,604 | -25,122 | -13,609 | -37,964 |
| Net Acquisitions | 129 | 129 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,636 | -1,573 | -1,352 | -968 | -13,501 |
| Other Investing Activity | -3,671 | -3,608 | -1,221 | -6,304 | -51,792 |
| Investing Cash Flow | $-52,520 | $-44,084 | $-26,344 | $-19,914 | $-89,756 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 15,771 |
| Debt Repayment | N/A | N/A | N/A | N/A | -66,300 |
| Common Stock Issued | 3,559 | 3,214 | 2,365 | 0 | 7,746 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | 80,584 |
| Dividend Paid | -7,922 | -7,922 | -7,922 | -7,922 | -3,691 |
| Other Financing Activity | -17,721 | 24,254 | 37,756 | 37,757 | 17,470 |
| Financing Cash Flow | $-22,084 | $19,546 | $32,199 | $29,835 | $51,580 |
| Exchange Rate Effect | -9,827 | -4,513 | -3,773 | 1,026 | -7,098 |
| Beginning Cash Position | 144,938 | 144,938 | 144,938 | 144,938 | 80,820 |
| End Cash Position | 183,766 | 203,204 | 204,034 | 180,117 | 144,938 |
| Net Cash Flow | $38,828 | $58,266 | $59,096 | $35,179 | $64,118 |
| Free Cash Flow | |||||
| Operating Cash Flow | 123,259 | 87,317 | 57,013 | 24,232 | 109,392 |
| Capital Expenditure | -49,371 | -40,956 | -25,223 | -13,673 | -38,791 |
| Free Cash Flow | 73,887 | 46,361 | 31,790 | 10,559 | 70,601 |